Characterization and validation 2024

Navigating the complexities of AAV and lentiviral vector characterization

Cell & Gene Therapy Insights 2024; 10(11), 1583–1589

DOI: 10.18609/cgti.2024.181

Published: 12 December
Interview
Susumu Uchiyama



Abi Pinchbeck, Editor, BioInsights, speaks to Susumu Uchiyama, Professor, Osaka University, about the challenges and successes of characterization techniques of AAV and lentivirus vectors used in gene therapies. They also discuss the complexities of viral vector particle composition and biophysical parameters, as well as the development of advanced analytical methods to streamline characterization for clinical trials.